Monkeypox Vaccine Storage Guidelines

By Esco Lifesciences 19 September, 2022

The Centers for Disease Control and Prevention (CDC) has released a statement regarding considerations for Monkeypox vaccination. Two vaccines are mentioned by the CDC that is approved to be used for the prevention of Monkeypox virus infection: namely JYNNEOS® and ACAM2000®.

What Do We Know About These Vaccines?

JYNNEOS® (Imvamune/Imvanex) is recommended for persons 18 and older who have been found to have a high risk of contracting smallpox or Monkeypox disease. The U.S. Food and Drug Administration (FDA) has approved it to prevent Monkeypox virus infection.

ACAM2000® is for active immunization against smallpox disease in individuals identified as being at high risk of infection. It is approved by the U.S. FDA for use against smallpox. Under an Expanded Access Investigational New Drug application, it is made available for use against Monkeypox.

Vaccine Storage Requirements

When it comes to administering potent vaccines, an efficient cold storage management system is critical. Failure to provide optimal storage for these irreplaceable products may result in spoilage and incur significant additional costs for health care providers.

Request for Quote

Investing in a reliable cold storage matters. Esco Scientific is a trusted provider of cold storage equipment worldwide. With more vaccines being rolled out, everyone is encouraged to work together to prevent the further spreading of the virus and follow science-based guidelines.

References:

[1] ACAM2000 [package insert]. Gaithersburg, MD USA: Emergent Product Development Gaithersburg Inc.; 2018

[2] Considerations for Monkeypox Vaccination. (2022, July 28). Centers for Disease Control and Prevention. https://www.cdc.gov/poxvirus/Monkeypox/considerations-for-Monkeypox-vaccination.html

[3] JYNNEOS [package insert]. Kvistgaard, Denmark: Bavarian Nordic A/S; 2021